Patents by Inventor Rebecca Voltan

Rebecca Voltan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9732359
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Grant
    Filed: December 8, 2015
    Date of Patent: August 15, 2017
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Istituto Superiore di Sanita
    Inventors: Bo Peng, Rebecca Voltan, Barbara Ensoli, Marjorie Robert-Guroff
  • Publication number: 20160090606
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Application
    Filed: December 8, 2015
    Publication date: March 31, 2016
    Inventors: Bo PENG, Rebecca VOLTAN, Babara ENSOLI, Marjorie ROBERT-GUROFF
  • Patent number: 9216214
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: December 22, 2015
    Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, Istituto Superiore di Sanita
    Inventors: Bo Peng, Rebecca Voltan, Barbara Ensoli, Marjorie Robert-Guroff
  • Publication number: 20150231229
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Application
    Filed: December 16, 2014
    Publication date: August 20, 2015
    Inventors: Bo PENG, Rebecca VOLTAN, Barbara ENSOLI, Marjorie ROBERT-GUROFF
  • Patent number: 8926987
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Grant
    Filed: November 17, 2005
    Date of Patent: January 6, 2015
    Assignees: The Government of The United States of America as represented by the Secretary of the Department of Health and Human Services, Istituto Superiore di Sanita
    Inventors: Bo Peng, Rebecca Voltan, Barbara Ensoli, Marjorie Robert-Guroff
  • Publication number: 20060115456
    Abstract: This invention provides improved replication-competent adenoviral vectors. The improved vectors have both a hybrid regulatory unit that provides for high level transgene expression. The vectors can be use, e.g., for therapeutic or prophylactic purposes.
    Type: Application
    Filed: November 17, 2005
    Publication date: June 1, 2006
    Applicants: The Government of the USA as represented by the Secretary of the Department of Health and Human, Istituto Superiore de Sanita
    Inventors: Bo Peng, Rebecca Voltan, Barbara Ensoli, Marjorie Robert-Guroff